Q1 2025 · 13F-HR
SILVERARC CAPITAL MANAGEMENT, LLCholdings as filed
Filed 2025-05-14 · accession 0001420506-25-001107
$489.0M
Reported value
69
Positions
2025-03-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 925050106 | VRNA | VERONA PHARMA PLC | $34.7M | 7.09% | 545,872 | Common | SOLE |
| N5749R100 | 2GH | MERUS N V | $34.1M | 6.98% | 811,021 | Common | SOLE |
| 670703107 | NUVL | NUVALENT INC | $31.1M | 6.37% | 439,018 | Common | SOLE |
| 00973Y108 | AKRO | AKERO THERAPEUTICS INC | $29.1M | 5.96% | 719,992 | Common | SOLE |
| 457669307 | INSM | INSMED INC | $24.5M | 5.01% | 321,366 | Common | SOLE |
| 483497103 | KALV | KALVISTA PHARMACEUTICALS INC | $19.6M | 4.01% | 1,698,984 | Common | SOLE |
| 92337F107 | VCYT | VERACYTE INC | $18.8M | 3.84% | 633,832 | Common | SOLE |
| 76243J105 | RYTM | RHYTHM PHARMACEUTICALS INC | $17.9M | 3.66% | 337,605 | Common | SOLE |
| 87164F105 | SNDX | SYNDAX PHARMACEUTICALS INC | $16.1M | 3.29% | 1,309,224 | Common | SOLE |
| M96088105 | URGN | UROGEN PHARMA LTD | $15.3M | 3.12% | 1,381,158 | Common | SOLE |
| 05370A108 | RNAGBP | AVIDITY BIOSCIENCES INC | $12.1M | 2.48% | 411,312 | Common | SOLE |
| 834203309 | SLNO | SOLENO THERAPEUTICS INC | $11.9M | 2.43% | 166,417 | Common | SOLE |
| 04351P101 | ASNDUSD | ASCENDIS PHARMA A/S | $11.8M | 2.41% | 75,751 | Common | SOLE |
| 254604101 | IRON | DISC MEDICINE INC | $11.7M | 2.40% | 236,471 | Common | SOLE |
| 68622P109 | ORIC | ORIC PHARMACEUTICALS INC | $11.5M | 2.35% | 2,060,240 | Common | SOLE |
| 282559103 | ETNBGBP | 89BIO INC | $11.0M | 2.25% | 1,510,498 | Common | SOLE |
| 29479A108 | ERAS | ERASCA INC | $10.1M | 2.06% | 7,367,996 | Common | SOLE |
| Y95308105 | WVE | WAVE LIFE SCIENCES LTD | $8.5M | 1.74% | 1,050,374 | Common | SOLE |
| 64125C109 | NBIX | NEUROCRINE BIOSCIENCES INC | $8.0M | 1.64% | 72,583 | Common | SOLE |
| 89422G107 | TVTX | TRAVERE THERAPEUTICS INC | $7.3M | 1.50% | 408,849 | Common | SOLE |
| 00973Y908 | — | AKERO THERAPEUTICS INC | $7.3M | 1.50% | 180,600 | CALL | SOLE |
| 38341P102 | GOSS | GOSSAMER BIO INC | $7.0M | 1.42% | 6,320,684 | Common | SOLE |
| 375558103 | GILD | GILEAD SCIENCES INC | $7.0M | 1.42% | 62,029 | Common | SOLE |
| G4444H101 | BBOT | HELIX ACQUISITION CORP II | $6.9M | 1.42% | 613,393 | Common | SOLE |
| 05479K106 | ELUT | ELUTIA INC | $6.8M | 1.38% | 2,670,056 | Common | SOLE |
| 74006W207 | PRAX | PRAXIS PRECISION MEDICINES I | $6.3M | 1.29% | 166,074 | Common | SOLE |
| 603170101 | MLYS | MINERALYS THERAPEUTICS INC | $5.4M | 1.10% | 338,354 | Common | SOLE |
| M25722105 | CGEN | COMPUGEN LTD | $4.2M | 0.86% | 2,895,430 | Common | SOLE |
| 87650L103 | TARS | TARSUS PHARMACEUTICALS INC | $4.2M | 0.85% | 81,331 | Common | SOLE |
| G01767105 | ALKS | ALKERMES PLC | $4.1M | 0.84% | 124,871 | Common | SOLE |
| 67576A100 | OCUL | OCULAR THERAPEUTIX INC | $4.0M | 0.83% | 551,570 | Common | SOLE |
| 10806X102 | BBIO | BRIDGEBIO PHARMA INC | $3.8M | 0.78% | 111,000 | Common | SOLE |
| 50127T109 | KURA | KURA ONCOLOGY INC | $3.8M | 0.78% | 581,369 | Common | SOLE |
| 15117B202 | CLDX | CELLDEX THERAPEUTICS INC NEW | $3.7M | 0.76% | 205,962 | Common | SOLE |
| 252828108 | DNTH | DIANTHUS THERAPEUTICS INC | $3.5M | 0.71% | 190,334 | Common | SOLE |
| 558868105 | MDGL | MADRIGAL PHARMACEUTICALS INC | $3.4M | 0.70% | 10,344 | Common | SOLE |
| 157085101 | CERS | CERUS CORP | $3.4M | 0.70% | 2,456,537 | Common | SOLE |
| 872381108 | TELA | TELA BIO INC | $3.4M | 0.69% | 2,771,288 | Common | SOLE |
| 152309100 | CNTA | CENTESSA PHARMACEUTICALS PLC | $3.3M | 0.68% | 232,758 | Common | SOLE |
| 89532M101 | TRVI | TREVI THERAPEUTICS INC | $3.3M | 0.68% | 530,000 | Common | SOLE |
| 09627Y109 | 2655787D | BLUEPRINT MEDICINES CORP | $3.3M | 0.68% | 37,345 | Common | SOLE |
| 86366E106 | GPCR | STRUCTURE THERAPEUTICS INC | $3.3M | 0.67% | 188,069 | Common | SOLE |
| 08205P209 | BNTC | BENITEC BIOPHARMA INC | $3.3M | 0.67% | 250,000 | Common | SOLE |
| 53635D202 | LQDA | LIQUIDIA CORPORATION | $3.2M | 0.65% | 214,057 | Common | SOLE |
| 69366J200 | PTCT | PTC THERAPEUTICS INC | $3.1M | 0.63% | 60,389 | Common | SOLE |
| 59267L107 | — | METSERA INC | $3.1M | 0.63% | 112,759 | Common | SOLE |
| 834203959 | — | SOLENO THERAPEUTICS INC | $3.0M | 0.62% | 42,500 | PUT | SOLE |
| 09075X108 | — | BIODESIX INC | $2.6M | 0.52% | 4,098,406 | Common | SOLE |
| 24661P807 | DCTH | DELCATH SYS INC | $2.4M | 0.50% | 191,470 | Common | SOLE |
| N90064101 | QURE | UNIQURE NV | $2.2M | 0.44% | 203,400 | Common | SOLE |
| G52694109 | KNSA | KINIKSA PHARMACEUTICALS INTL | $2.0M | 0.40% | 88,215 | Common | SOLE |
| 83422E204 | SLDB | SOLID BIOSCIENCES INC | $1.7M | 0.34% | 452,239 | Common | SOLE |
| 20454B104 | CMPX | COMPASS THERAPEUTICS INC | $1.7M | 0.34% | 874,869 | Common | SOLE |
| 12529R107 | CCCC | C4 THERAPEUTICS INC | $1.4M | 0.29% | 882,300 | Common | SOLE |
| 483119202 | KALAEUR | KALA BIO INC | $1.4M | 0.29% | 246,079 | Common | SOLE |
| 90466Y103 | — | UNICYCIVE THERAPEUTICS INC | $1.4M | 0.28% | 2,413,489 | Common | SOLE |
| 00370M103 | ABVX | ABIVAX SA | $1.3M | 0.27% | 210,901 | Common | SOLE |
| 50015M109 | KOD | KODIAK SCIENCES INC | $1.2M | 0.25% | 441,807 | Common | SOLE |
| 829401108 | SION | SIONNA THERAPEUTICS INC | $1.2M | 0.24% | 114,138 | Common | SOLE |
| N44821101 | IFRX | INFLARX NV | $1.2M | 0.24% | 1,161,567 | Common | SOLE |
| 59045L106 | — | MERSANA THERAPEUTICS INC | $1.1M | 0.22% | 3,088,505 | Common | SOLE |
| 60785L207 | — | MODULAR MED INC | $1.0M | 0.21% | 958,881 | Common | SOLE |
| 75041J101 | RADX | RADIOPHARM THERANOSTICS LTD | $901,423 | 0.18% | 187,406 | Common | SOLE |
| 002942100 | AARD | AARDVARK THERAPEUTICS INC | $897,415 | 0.18% | 119,496 | Common | SOLE |
| 98420N105 | XENE | XENON PHARMACEUTICALS INC | $339,560 | 0.07% | 10,121 | Common | SOLE |
| G29687103 | AVDL | AVADEL PHARMACEUTICALS PLC | $308,236 | 0.06% | 39,366 | Common | SOLE |
| 35168W103 | GUTS | FRACTYL HEALTH INC | $282,563 | 0.06% | 237,448 | Common | SOLE |
| 92243A200 | VXRT | VAXART INC | $278,317 | 0.06% | 683,825 | Common | SOLE |
| 77313F114 | RCKTW | ROCKET PHARMACEUTICALS INC | $4,927 | 0.00% | 104,828 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.